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Abstract
What’s known on the subject? and What does the study add?
Öz
Amaç: Ürogenital örneklerden izole edilen Ureaplasma urealyticum suşlarının antibiyotiklere karşı duyarlılıklarının zaman içerisinde değişip 
değişmediğinin değerlendirilmesidir.
Gereç ve Yöntem: Hastane kayıtları retrospektif olarak incelenerek 2008 ve 2013 yılları içerisinde ürogenital örneklerde U. urealyticum üreyen 
olgular belirlenmiştir. Ayrıca 2001 yılında tebliğ ettiğimiz olgular göz önünde bulundurularak zaman içerisindeki değişim incelenmiştir.
Bulgular: U. urealyticum izole edilen 60 hastada tetrasiklin ve doksisikline karşı yüksek oranlarda duyarlılık gözlenmiştir. Ofloksasin ve siprofloksasine 
karşı direncin yüksek oranlarda olduğu gözlenmiştir. 2008 ve 2013 yılları karşılaştırıldığında antibiyotiklere karşı direnç oranlarında anlamlı bir 
farklılık gözlenmemiştir. 2001 yılı kayıtları 2008 ve 2013 yılları kayıtları ile karşılaştırıldığında ofloksasin ve siprofloksasine karşı direncin istatistiksel 
olarak anlamlı bir şekilde arttığı gözlenmiştir (p<0,0005).
Sonuç: U. urealyticum suşları kinolonlara karşı yüksek oranda direnç göstermektedirler. Zaman içerisinde direnç gelişimi artmaktadır. Tetrasiklin ve 
doksisikline karşı duyarlılık yüksek oranlarda devam etmektedir. Kültür yapılamayan olgularda uygulanacak olan ampirik tedavide bu durumun göz 
önünde bulundurulması yararlı olacaktır.
Anahtar Kelimeler: Ureaplasma urealyticum, Kinolonlara direnç, Üretrit
Objective: To assess any change in the antibiotic sensitivity of Ureaplasma urealyticum strains isolated from urogenital samples in the course of time.
Materials and Methods: Hospital records were retrospectively examined and cases with growth of U. urealyticum in urogenital samples in the years 
2008 and 2013 were identified. Furthermore, the change in the course of time was examined by taking into consideration the cases we reported in 2001.
Results: Higher rates of sensitivity against tetracycline and doxycycline were observed in 60 patients with isolated U. urealyticum. Higher rates of 
resistance against ofloxacin and ciprofloxacin were observed. A significant difference was found in resistance against antibiotics when the records 
of 2008 and 2013 were compared. A statistically significant increase was found in resistance against ofloxacin and ciprofloxacin when the records 
of 2001 were compared with the records of 2008 and 2013 (p<0.0005).
Conclusion: U. urealyticum strains demonstrated high levels of resistance to quinolones. Resistance development is increasing in the course of 
time. Sensitivity against tetracycline and doxycycline has continued at high rates. It would be beneficial to consider these results during empirical 
treatment to be applied in cases ineligible for culturing. 
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In this study, resistance of Ureaplasma urealyticum strains isolated from urogenital samples to antibiotics in 2001, 2008 and 2013 is 
evaluated. Sensitivity to tetracycline and doxycycline was found to be continued at high rates. High resistance to ofloxacin and ciprofloxacin 
were observed.
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Introduction 
Ureaplasma urealyticum is a species belonging to the genus 
Ureaplasma and the family of Mycoplasmataceae in the order 
mycoplasmalates and class of Mollicutes of bacteria. Bacterial 
species U. urealyticum and Ureaplasma parvum under the 
Ureaplasma genus are found to be disease-causing agents in 
human beings (1). 
This bacterium was initially recognized during the 1950’s after 
being isolated in non-gonococcal urethritis cases (2). Later 
during the 1960’s, it was renamed as T-mycoplasmas after 
its characteristics were better understood (3). Finally in 1974, 
the current name U. urealyticum was given on the basis of its 
impact on urea and other metabolic characteristics (4). Fourteen 
serotypes of U. urealyticum have been defined. Serotypes 1, 3, 
6, and 14 were defined as U. parvum since they are responsible 
more likely from gynecological and neonatal infections. 
However, other serotypes are still named as U. urealyticum (5).
U. urealyticum causes upper respiratory tract and lower urinary 
tract infections in humans. Urethritis, cystitis, epididymo-
orchitis, prostatitis, salpingitis and pelvic inflammatory disease 
are among the resulting diseases (6,7). It is also suggested to 
increase risk of stone formation due to its urea breakdown effect 
(8). It is also known to be a significant risk for adverse pregnancy 
outcomes and complications of preterm birth (9). It may rarely be 
present in intra-articular fluids.
U. urealyticum does not grow in routine bacterial culture media. 
Specific culture media are used to detect this bacterium and 
implement antibiotic sensitivity tests. Although techniques, 
such as polymerase chain reaction, are used for diagnostic 
purposes, such methods do not provide any information on 
antibiotic sensitivity.
Absence of cell wall is the main specific characteristic of this 
family of bacteria. Therefore, antibiotics acting by impairing 
cell wall synthesis are not efficacious on this group of bacteria. 
Tetracycline, fluoroquinolone and macrolides are among the 
efficacious antibiotics. Development of resistance in particular 
against fluoroquinolone is observed in the course of time.
This study aims at assessing antibiotic sensitivity of U. 
urealyticum and the antibiotic resistance developing in the 
course of time.
Materials and Methods 
This is a retrospective study. We analyzed the records of our 
hospital and identified the results positive for bacterium U. 
urealyticum in the samples taken from patients attended our 
urology unit in 2008 and 2013. The test reports were documented 
and examined.
Mycoplasma IST 2 test kit (BioMérieux, Marcy- I’Etoile, France) is 
used in our hospital for the diagnosis of Mycoplasma infections. 
This kit allows for both isolation of bacteria and sensitivity test 
against nine antibiotics.
Resistance against antibiotics was assessed, by comparing the 
test results obtained in 2008 and 2013 with the use of chi-
square test. By this way, it was investigated whether or not 
there occurred any difference in antibiotic resistance within a 
period of five years.
Statistical Analysis
The results of these two years were compared with the rate of 
antibiotic resistance of U. urealyticum strains isolated within 
the first six months of 2000, as presented in 2001, and thus, 
the difference in resistance within a period of 14 years was 
also investigated. Chi-square test was used for this assessment. 
Samples (10) obtained in 2001 were examined using the 
Mycoplasma IST kit (BioMérieux, Marcy-I’Etoile, France) and 
sensitivity to seven antibiotics was tested.
Results 
Results of 60 patients were accessible from the hospital records. 
26 of these patients were tested in 2008, whereas 34 in 2013. The 
mean age of the patients was 37.9±11.4 years (21-74). Twenty-five 
patients were female and all samples taken were urine.
Thirty-five patients were male and U. urealyticum was isolated 
from the urine of 7 patients and ejaculate of 28 patients.
Antibiotic sensitivity of the U. urealyticum strains isolated in 
2008 and 2013 is given is Table 1. Among the nine antibiotics 
tested, highest sensitivity rates were observed in tetracycline 
and doxycycline and highest resistance rates in ofloxacin 
and ciprofloxacin. Resistance to ofloxacin was found in 12%, 
whereas this rate was 62% for ciprofloxacin. No statistically 
significant difference was found in terms of the resistance rate 
against the nine tested antibiotics when data of 2008 and 2013 
were compared (p>0.5). 
When the antibiotic resistance rate of the strains isolated in 
2001 was compared with that of the strains isolated in 2008 and 
2013; the increase in resistance to ofloxacin and ciprofloxacin 
was observed to be statistically significant (p<0.0005). No 
statistical significant change was found in resistance against 
other antibiotics (p>0.5).
The rate of antibiotic resistance of U. urealyticum strains resulting 
from various studies are given in Table 2 (10,11,12,13,14,15,16). 
This table, in particular, underlines the high level of resistance 
to fluoroquinolones.
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Discussion 
U. urealyticum is a bacterium that potentially causes upper 
respiratory tract, lower urinary tract and genital system 
infections in adults. It is also known to play a role in neonatal 
infections. Inability of the growth of this bacterium in the 
routinely used culture media makes it difficult for isolation. 
Samples of increasing number of patients are isolated in the 
recent years thanks to the media, which are specially developed 
for the growth of this specific bacterium and are now in routine 
practice (10,16).
U. urealyticum is innately resistant to certain antibiotics given 
its absence of bacterial cell wall. Beta-lactam antibiotics 
including penicillin and cephalosporin, glycopeptides including 
vancomycin and teicoplanin and phosphomycin are the 
antibiotics inefficacious against this bacterium. Furthermore, 
polymyxin, sulphonamide, trimethoprim, nalidixic acid and 
rifampicin are also not efficacious. When the above given 
matters are taken into consideration, it is understood that 
majority of the antibiotics used in empirical treatment in daily 
practice have no effect on U. urealyticum.
The main antibiotics efficacious on U. urealyticum are 
tetracyclines, macrolides, fluoroquinolones and pristinamycin. 
Although fluoroquinolones are the most commonly used 
antibiotics, development of resistance to these antibiotics is a 
major concern.
In the recent 4 years, the incidence of U. urealyticum has been 
increasing continuously. Therefore, we wonder if the antimicrobial 
resistance of  U.  urealyticum  and  Mycoplasma  hominis  has 
changed. The fluoroquinolone resistance rate in Ureaplasma spp. 
varies widely among different countries and studies. For 
instance, in a recent study carried out in Switzerland, Schneider 
et al. (11) reported a rate of non-susceptibility to ciprofloxacin 
of 19.4%, while in a recent study in Italy, 41% of isolates 
were ciprofloxacin-resistant (12). In our study, the rate of 
ciprofloxacin resistance was 62%. Diaz et al. (13) reported 
that less than 35% of  U. urealyticum  isolates in Cuba were 
resistant to minocycline, pefloxacin, doxycycline, tetracycline, 
clindamycin, and azithromycin. They showed that the rate of 
resistance to ofloxacin, clarithromycin, and erythromycin were 
64.3%, 63%, and 46.1%, respectively. In a study conducted 
in Turkiye on pregnant women, Bayraktar et al. (14) reported 
that the rate of resistance of genital mycoplasmas to 
doxycycline, josamycin, ofloxacin, erythromycin, tetracycline, 
ciprofloxacin, azithromycin, clarithromycin, and pristinamycin 
was 0%, 0%, 81.3%, 34.4%, 0%, 84.4%, 25%, 12.5%, and 0%, 
Table 1. Antibiotic sensitivity for U. urealyticum in 2008 and 2013 n (%)
2008 2013
Antibiotic S I R S I
Tetracycline 26 (100) 0 (0) 0 (0) 34 (100) 0 (0)
Doxycycline 26 (100) 0 (0) 0 (0) 34 (100) 0 (0)
Erythromycin 22 (84) 3 (12) 1 (4) 31 (91) 0 (0)
Clarithromycin 22 (84) 2 (8) 2 (8) 30 (88) 1 (3)
Azithromycin 23 (88) 3 (12) 0 (0) 31 (91) 0 (0)
Josamycin 24 (92) 1 (4) 1 (4) 34 (100) 0 (0)
Pristinamycin 23 (88) 1 (4) 2 (8) 34 (100) 0 (0)
Ofloxacin 10 (38) 13 (50) 3 (12) 10 (29) 20 (59)
Ciprofloxacin 1 (4) 9 (34) 16 (62) 3 (9) 10 (29)
S: Sensitive, I: Intermediate, R: Resistance
Table 2. Antibiotic resistance rates against Ureaplasma urealyticum as obtained in various studies (%)
Author n Gender Tet Dox Ery Clair Azt Jos Prs Ofl Cip
Saraçoğlu and Aydınlı (10) 18 M 0 5.6 0 0 0 - - 0 0
Schneider et al. (11) 140 F, M -- -- 1.9 4.9 1 -- -- 9.7 19.4
Pignanelli et al. (12) 542 F 2.9 1.7 18.9 14.6 6.3 3.7 2.1 5.6 40.7
Bayraktar et al. (14) 27 F 0 0 34.7 12.5 25 0 0 81.3 84.4
Diaz et al. (13) 150 F 16 46 63 64
Leli et al. (16) 152 M, F -- 0 0 -- 0 0 0 27.6 66.4
This study 60 M, F 0 0 7 8 5 2 3 12 62
M: Male, F: Female, Tet: Tetracycline, Dox: Doxycycline, Ery: Erythromycin, Clair: Clarithromycin, Azt: Azithromycin, Jos: Josamycin, Prs: Pristinamycin, Ofl: Ofloxacin, Cip: Ciprofloxacin
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respectively, which was the report with the most similarity to 
our study. In their study conducted on South African pregnant 
women, Redelinghuys et al. (15) reported that susceptibility 
of  Ureaplasma  spp. to levofloxacin and moxifloxacin was 
59% and 98%, respectively. They showed that mixed isolates 
(Ureaplasma spp. and  M. hominis) were highly resistant to 
erythromycin (97%) and tetracycline (97%).
Antibiotic resistance of U. urealyticum strains isolated from 
the urogenital samples obtained in 2001, 2008 and 2013 were 
investigated in this study. High rates of sensitivity to tetracycline 
and doxycycline were observed to continue. Resistance to 
ofloxacin and ciprofloxacin was found to be at high rates. High 
rates of resistance or these two antibiotics were also observed in 
other studies in the literature as summarized in Table 2.
Study Limitations
Due to low number of cases, patients were not sub-grouped 
according to gender, age and mode of sampling. It would be 
useful to investigate any potential difference in terms of 
antibiotic sensitivity among the sub-groups of gender, age 
groups and modes of sampling as urine, ejaculate, urethral 
discharge, vaginal discharge or cervical smear in larger series. 
Conclusion
It would be beneficial to consider these sensitivity rates in the 
treatment of patients with suspected U. urealyticum infection 
but not eligible for culturing. Our study is important in terms of 
demonstrating a statistically significant increase in resistance to 
ofloxacin and ciprofloxacin within a period of 14 years.
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